CORC  > 复旦大学上海医学院
Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer
Gu, Yu; Chen, Tianxiang; Li, Guangliang; Xu, Cong; Xu, Zhenzhen; Zhang, Jing; He, Kuifeng; Zheng, Linyan; Guan, Zhonghai; Su, Xinyun
刊名ONCOTARGET
2017
卷号8期号:32
关键词breast cancer tamoxifen resistance prognosis beclin 1 HER2
ISSN号1949-2553
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3620852
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Gu, Yu,Chen, Tianxiang,Li, Guangliang,et al. Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer[J]. ONCOTARGET,2017,8(32).
APA Gu, Yu.,Chen, Tianxiang.,Li, Guangliang.,Xu, Cong.,Xu, Zhenzhen.,...&Teng, Lisong.(2017).Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer.ONCOTARGET,8(32).
MLA Gu, Yu,et al."Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer".ONCOTARGET 8.32(2017).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace